Legend Biotech (LEGN) Cash & Current Investments (2019 - 2025)
Legend Biotech (LEGN) posted Cash & Current Investments of $901.9 million for Q4 2025, up 223.39% on a QoQ basis from $278.9 million in Q3 2025, and up 214.58% year-over-year from $286.7 million in Q4 2024.
Legend Biotech (LEGN) Cash & Current Investments (2019 - 2025) Analysis & Trends
Legend Biotech's Cash & Current Investments history runs 7 years deep, the most recent figure standing at $901.9 million for Q4 2025.
- Quarterly Cash & Current Investments rose 214.58% year-over-year to $901.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $901.9 million (up 214.58% YoY) and the FY2025 annual result came in at $901.9 million, up 214.58% from the prior year.
- Cash & Current Investments was $901.9 million for Q4 2025 at Legend Biotech, up from $278.9 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $1.4 billion in Q2 2023 and bottomed at $50.7 million in Q2 2024.
- A 5-year average of $621.8 million and a median of $465.0 million in 2021 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2024 — Cash & Current Investments plunged 96.43% — and 2025, when it surged 425.88%.
- Legend Biotech's Cash & Current Investments stood at $688.9 million in 2021, then jumped by 41.03% to $971.6 million in 2022, then soared by 31.57% to $1.3 billion in 2023, then slumped by 77.57% to $286.7 million in 2024, then soared by 214.58% to $901.9 million in 2025.
- Business Quant data shows LEGN's Cash & Current Investments at $901.9 million in Q4 2025, $278.9 million in Q3 2025, and $266.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | 901.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 901.90 Mn |
| Sep 30, 2025 | 278.89 Mn |
| Jun 30, 2025 | 266.59 Mn |
| Mar 31, 2025 | 441.70 Mn |
| Dec 31, 2024 | 286.70 Mn |
| Sep 30, 2024 | 309.48 Mn |
| Jun 30, 2024 | 50.69 Mn |
| Mar 31, 2024 | 1.05 Bn |
| Dec 31, 2023 | 1.28 Bn |
| Sep 30, 2023 | 1.15 Bn |
| Jun 30, 2023 | 1.42 Bn |
| Mar 31, 2023 | 845.76 Mn |
| Dec 31, 2022 | 971.63 Mn |
| Sep 30, 2022 | 652.73 Mn |
| Jun 30, 2022 | 279.78 Mn |
| Mar 31, 2022 | 277.79 Mn |
| Dec 31, 2021 | 688.94 Mn |
| Sep 30, 2021 | 388.37 Mn |
| Jun 30, 2021 | 488.22 Mn |
| Mar 31, 2021 | 412.30 Mn |